Navigation Links
NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
Date:8/5/2008

NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS) announced today that the new Southern Florida stem cell collection center located in Coral Gables, a suburb of Miami, is targeted to open in September. The center is being opened pursuant to an agreement with CelVida LLC. With the opening of this center, NeoStem has secured a key geographic stronghold in an area that is open to a large U.S. market as well as a growing sophisticated South American presence.

Chester Amedia, Jr. MD, FACP, is the Founder and President of CelVida LLC and has had extensive business and patient care experience in the fields of disease management and extracorporeal therapy. "We are thrilled to be part of what many believe to be an emerging "Stem Cell Revolution" and have chosen to strategically align with NeoStem to provide individuals looking for a proactive approach to their future medical care the opportunity to have their stem cells collected and preserved for use in the future in the event of medical need," stated Dr. Amedia. "It is estimated that by 2017 there will be as many as 2 million annual procedures that will include stem cell based therapies for diabetes, orthopedic injuries, cardiovascular disease, inflammatory diseases, among others."

"We are thrilled to be working with such an accomplished physician who has demonstrated success in building a flourishing medical business. We believe that patient specific stem cell collection and storage one day will be viewed as being as routine as securing health insurance. We continue to see an abundance of evidence in the scientific literature as data from clinical trials supports the proposition that autologous adult stem cell therapies are emerging as an important measure in repairing degenerated, damaged and diseased tissue (the three "Ds" of aging)," said Robin Smith, MD, CEO of NeoStem.

About CelVida LLC

CelVida was organized to develop a network of personal self-care centers in key metropolitan markets around the country. The CelVida network intends to make the simple process of stem cell collection and storage available to individuals proactively seeking healthcare options that embrace new technologies.

About NeoStem, Inc.

NeoStem is managing a network of adult stem cell collection centers, enabling people (through its proprietary technology) to donate and store their own (autologous) stem cells when they are young and/or relatively healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's periodic filings with the Securities and Exchange Commission.

Contact:

NeoStem, Inc.

Robin Smith, Chief Executive Officer

T: 212-584-4180

E: rsmith@neostem.com

http://www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
2. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
3. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
4. NeoStem to Expand Stem Cell Collection Center Network to Florida
5. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
6. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
7. NeoStem to Present at Third Annual Stem Cell Summit in New York City
8. NeoStem Announces NY State License for Adult Stem Cell Collection
9. Principle of Recursive Genome Function Supersedes Dogmas; By Andras Pellionisz, Online Ahead of Print; (Scientific Visionary Vindicated)
10. Breakthroughs Ahead, Endocrine Society Tells Security Analysts
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced today ... demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis program ... new website, https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. ...
(Date:12/8/2016)... Dec. 8, 2016  Soligenix, Inc. (OTCQB: SNGX) ... focused on developing and commercializing products to treat ... need, announced today the long-term follow-up data from ... a first-in-class Innate Defense Regulator (IDR), in the ... neck cancer patients undergoing chemoradiation therapy (CRT).  The ...
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/7/2016)... ... 07, 2016 , ... A new study published in the ... treated, advanced pancreatic cancer, liquid biopsies are not yet an adequate substitute for ... blood sampling may improve the value of a blood-based test.” The study was ...
Breaking Biology Technology:
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
(Date:11/17/2016)... OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it has ... using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer storage ... ... ... Setting up ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
Breaking Biology News(10 mins):